Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mochida

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mochida's Japan sales performance.

Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today

Pfizer, BioNTech to submit emergency use request for COVID-19 vaccine to FDA today

Rolling submissions for BNT162b2 are already ongoing in a number of regions globally, including the UK, the EU, Australia, Canada and Japan.

Roche’s flu pill Xofluza moves closer towards EU approval

Roche’s flu pill Xofluza moves closer towards EU approval Xofluza was originally discovered and developed by Japanese pharma company Shionogi, which retains the rights to Xofluza in Japan and Taiwan – Roche holds the remaining worldwide rights to the drug.

AZ confirms the UK's MHRA has started rolling review of its COVID-19 vaccine

AZ confirms the UK's MHRA has started rolling review of its COVID-19 vaccine All phase 3 trials have now resumed, including in the US, UK, Brazil, South Africa and Japan.

Keytruda growth helps Merck to offset COVID-19 impact in Q3

Keytruda growth helps Merck to offset COVID-19 impact in Q3 This growth was particularly driven by higher sales volumes in the US, Europe and Japan, which can be attributed to an increased demand for pneumococcal vaccination during the COVID-19 pandemic.

AZ’s COVID-19 vaccine shows promise in younger and older adults

AZ’s COVID-19 vaccine shows promise in younger and older adults The large-scale trial has now resumed in all global locations, including the US, UK, Brazil, South Africa and Japan.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics